Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Drug Targets|February 6, 2015
Predictive Diagnostic Pathology in the Target Therapy Era in Breast CancerCaterina Marchio, Davide Balmativola, Roberta Castiglione, et al.
Expert Review of Molecular Diagnostics|January 30, 2016
The impact of sequencing on diagnosis and treatment of malignant melanomaRoberta Castiglione, Michaela A Ihle, Carina Heydt, et al.
Cancers|December 10, 2021
Mismatch Repair Deficiency and Somatic Mutations in Human Sinonasal TumorsLena Hieggelke, Carina Heydt, Roberta Castiglione, et al.
Journal of Cancer Science and Clinical Therapeutics|January 30, 2023
<i>MET</i>-FISH Evaluation Algorithm: Proposal of a Simplified MethodRoberta Castiglione, Christina Alidousty, Barbara Holz, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 22, 2018
Comparison of the genomic background of MET-altered carcinomas of the lung: biological differences and analogiesRoberta Castiglione, Christina Alidousty, Barbara Holz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2017
Mechanisms of Primary Drug Resistance in <i>FGFR1</i>-Amplified Lung CancerFlorian Malchers, Meryem Ercanoglu, Daniel Schütte, et al.
The Journal of Molecular Diagnostics : JMD|December 22, 2018
Combined Targeted Resequencing of Cytosine DNA Methylation and Mutations of DNA Repair Genes with Potential Use for Poly(ADP-Ribose) Polymerase 1 Inhibitor Sensitivity TestingChristina Grimm, Axel Fischer, Angela M Farrelly, et al.
Cell Reports|October 26, 2018
The Cdkn1a<sup>SUPER</sup> Mouse as a Tool to Study p53-Mediated Tumor SuppressionAlessandro Torgovnick, Jan Michel Heger, Vasiliki Liaki, et al.
European Journal of Cancer (Oxford, England : 1990)|December 15, 2022
Resistance to MET inhibition in MET-dependent NSCLC and therapeutic activity after switching from type I to type II MET inhibitorsRichard Riedel, Jana Fassunke, Hannah L Tumbrink, et al.
Nature Communications|February 22, 2018
Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemiaCarmen D Herling, Nima Abedpour, Jonathan Weiss, et al.
Pageof 2